Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Hemic or immune system
Reexamination Certificate
2005-06-28
2005-06-28
Wehbé, Anne Marie S. (Department: 1632)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Hemic or immune system
C424S553000, C424S093100, C424S093300, C424S093200, C424S093210, C424S130100
Reexamination Certificate
active
06911220
ABSTRACT:
The invention provides methods for restoring or inducing immunocompetence, the methods including the step of introducing donor thymic tissue into the recipient. The invention also provides methods for inducing tolerance in a recipient including introducing donor thymic tissue into the recipient. The invention further provides methods of inducing tolerance including administering to the recipient a short course of help reducing treatment or administering a short course and methods of prolonging the acceptance of a graft by administering a short course of an immunosuppressant.
REFERENCES:
patent: 5199942 (1993-04-01), Gillis
patent: 5658564 (1997-08-01), Sykes et al.
patent: WO 93/09815 (1993-05-01), None
patent: WO 95/21527 (1995-08-01), None
Verma et al. (1997) Science, vol. 389, 239-242.
Marshall et al. (1997) Nature, vol. 269, 1050-1055.
Orkin et al. (1995) “Report and Recommendations . . . ”.
Kaufman et al. (1995) Annu. Rev. Immunol., vol. 13, 339-367.
Sablinski et al. (1997) Surgery, vol. 121, 381-391.
Sachs (1993) Ann. Rev. Thorac. Surg. , vol. 56, 1221-1227.
Borleffs et al. (1983) Hear Trans., vol. 11 (2), 111-117.
Ilstad et.al.; Mixed Xenogeneic Chimeras (Rat + Mouse To Mouse), 1992, Transplantation, vol. 53: 815-822.
Monaco, A.P., A. Liegeois, M.L. Wood, and A.W. Clark. 1975. Active Enhancement of Tissue Allografts with Antilymphocyte Serum and bone Marrow. In Advances in Nephrology, vol. 5. C. a. M. Hamburger ed., Chicago.
Monaco, A.P., W.M. Abbott, H.B. Othersen, R.L. Simmons, M.L. Wood, M.H. Flax, and P. S. Russell. 1966. Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science 153:1264.
Monaco, A.P., M.L. Wood, J.G. Gray, and P.S. Russell. 1966. Studies on heterologous antilymphocyte serum in mice. II. Effect on the immune response. J. Immunol 96:229.
Wood, M.L., J.J. Gozzo, and A.P. Monaco. 1972. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments. Transplant Proc. 4:523.
Monaco, A.P., and D.J. Franco. 1969. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity. Transplant Proc 1:474.
Monaco, A.P., and M.L. Wood. 1970. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Transplant Proc 2:489.
Wood, M.L., A.P. Monaco, J.J. Gozzo, and A. Liegeois. 1971. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc 3:676.
Wood, M.L., J.J. Gozzo, G. Heppner, and A.P. Monaco. 1972. Cell-mediated immunity and serum blocking factor in tolerance produced in mice with antilymphocyte serum and bone marrow cell infusion. Transplant Proc 4:383.
Caridis, D.T., A. Liegeois, I. Barrett, and A.P. Monaco. 1973. Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow, Transplant Proc 5:671.
Wood, M.L., G. Heppner, J.J. Gozzo, and A. P. Monaco. 1973. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion. Transplant Proc 5:691.
Wood, M.L., and A.P. Monaco. 1980. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice. Transplantation 29:196.
Maki, T., R. Gottschalk, F.N. Hornsy, H. Okazaki, M.L. Wood, and A.P. Monaco. 1981. In vitro analysis of immune reactivity in ALS-treated, bone marrow injected mice bearing enhanced skin allografts. Trans. 13:596.
Monaco, A.P., et al. 1976. Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt. Surgery 79:384.
Wood, M.L., and A.P. Monaco. 1979. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice. Transplant Proc. 11:1023.
Monac, A.P., et al. 1971. Use of low dose of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection. Transplant Proc. 3:680.
Asherson et al. “Adult thymectomy prevention of the appearance of suppressor T cells which depress contact sensativity to picryl chloride and reversal of adult thymetomy effect by thymus extract”,Eur. J. Immunol., 6:699-703 (1976).
Baliga et al. “CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity”,Transplantation, 58:1082-1090 (1994).
Bani-Sacchi et al., “Immunocytochemical and ultrastructural changes of islet cells in rats treated long-term with cyclosporine at immunotherapeutic doses,”Transplantation, 49:982-987 (1990).
Beko II et al., “Mechanisms of prior blood transfusion-cyclosporine-induced tolerance—A potential role for immune-cellular chimerism,”Transplantation Proceedings, 23:147-148 (1991).
Bellgrau and Selawry, “Cyclosporine-Induced Tolerance to Intratesticular Islet Xenografts,”Transplantation, 50:654-657 (1990).
Beschorner et al., “Transplant Tolerance Develops after Cyclosporine,”Laboratory Invest., 68:122a (1993).
Bom-van Noorlos et al., “Cyclosporine A in Orthotopic Porcine Liver Transplantation,”Eur. Surg. Res., 16:329-335 (1984).
Borleffs et al., “Cyclosporin A as Optimal Immunosuppressant After Kidney Allografting in Rhesus Monkeys,”Heart Transplantation, 2(2):111-117 (1983).
Calne et al., “Prolonged survival of pig orthotopic heart grafts treated with cyclosporin a,”The Lancet, 1:1183-1184 (1978).
Cattral et al., “Transplantation of purified single-donor canine islet allografts with cyclosporine,”Transplantation, 47:583-587 (1989).
Collier et al., “Alternate-Day Cyclosporine A and Azathiprine in Experimental Dog Renal Allografts,”Transplantation Proceedings, 19:1279-1280 (1987).
Cooper et al., “Effects of Cyclosporine and Antibody Adsorption on Pig Cardiac Xenografts Survival in the Baboon,”J. Heart Transplantation, 7:238-246 (1988).
Davie et al., “Role of T Lymphocytes in the Humoral Immune Response,”J. Immunol., 113:1438-1445 (1974).
Dick et al. “Genetic manipulation of hematopoietic stem cell with retrovirus vectors”,TIG Reviews, 2:165-170 (1986).
Dugoni et al., “Evidence that Cyclosporine Prevents Rejection and Recurrent Diabetes in Pancreatic Transplants in the BB Rat,”Transplantation, 49:845-848 (1990).
Fischel et al. “Prolonged survival of a discordant cardiac xenograft in a rhesus monkey”,Transplant. Proceedings, 23:589-590 (1991).
Fishbein, J. F. et al., “Development of Tolerance to Class II-Mismatched Renal Transplants after a Short Course of Cyclosporine Therapy in Miniature Swine,”Transplantation, 57:1303-1308 (1994).
Fishbein, J. F. et al., “Interleukin-2 Reverses the Ability of Cyclosporine to Induce Tolerance to Class I Disparate Kidney Allografts in Miniature Swine,”Transplantation Proceedings, 25:322-323 (1993).
Florack et al., “Effect of Short-Term High-Dose Cyclosporine Treatment on Endocrine Funtion of Segmental Pancreatic Grafts,”Transplantation Proceedings, 23:1593-1595 (1991).
Flye, “Histologic Evidence of Modification of Liver Allograft Rejection in Inbred Miniature Swine by Cyclosporine,”Transplantation Proceedings, 15:2983-2985 (1983).
Flye et al., “Prevention of Fatal Rejection ofSLA-Mismatched Orthotopic Liver Allografts in Inbred Miniature Swine by Cyclosporin-A,”Transplantation Proceedings,15:1269-1271 (1983).
Fukuzawa et al., “Effect of cyclosporin A on T cell immunity I. Dose-dependent suppression of different murine T helper cell pathways,”Eur. J. Immunol., 19:49-56 (1989).
Green et al., “Induction of Specific Tolerance in Rabbits by Kidney Allografting and Short Periods of Cyclosporin-A Treatment,”The Lancet, 123-125 (Jul. 21, 1979).
Green et al., “Extensive prolongation of rabbit kidney allograft survival after short ter
S. Wehbé Anne Marie
The General Hospital Corporation
LandOfFree
Allogeneic and xenogeneic transplantation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Allogeneic and xenogeneic transplantation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allogeneic and xenogeneic transplantation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3491439